Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
01 3Omgene Life Sciences Pvt. Ltd
02 42care4
03 15Abacus Medicine
04 1Amryt Pharma
05 2Ascent Innovative Medicines
06 5Avet Pharmaceuticals
07 5Bioindustria L.I.M. Spa
08 3Biological E
09 1CHIESI USA INC
10 4Campus Pharma AB
11 1Camurus
12 1Cc Pharma Nordic Aps
13 3Central Procurement & Supplies Unit
14 6Chemi SpA
15 2Cherubino Limited
16 1EJ Busuttil Ltd
17 3Ebb Medical
18 2Farmak JSC
19 2Flagship Biotech International Pvt. Ltd
20 6Fresenius Kabi AB Brunna
21 5Fresenius Kabi USA
22 4GLAND PHARMA LIMITED
23 7GP Pharm
24 12Generic Health
25 1Hainan Shuangcheng Pharmaceuticals
26 4Hospira, Inc.
27 7Italfarmaco S.p.A
28 3LIFEPHARMA SpA
29 1LYOMARK PHARMA GMBH DE 82041 Oberhaching near Munick
30 4Labatec Pharm
31 3Lifepharma
32 15Medartuum
33 5Meitheal Pharmaceuticals
34 3Mepha Pharma
35 2Montage Laboratories
36 4Naprod Life Sciences
37 3Northern Medical Group Aps
38 60Novartis Pharmaceuticals Corporation
39 6Novartis South Africa (Pty) Ltd
40 12ORIFARM GROUP AS
41 4Omega Laboratories Limited
42 7Paranova Pharmaceuticals Ab
43 6Pfizer Inc
44 3Pluviaendo
45 3Ratiopharm Espana Sa
46 5Sagent Pharmaceuticals
47 33Sun Pharmaceutical Industries Limited
48 12Teva Pharma Australia
49 19Teva Pharmaceutical Industries
50 2Uab Bijon Medica
51 9Unimedic AB
52 1Varian Pharmed
53 6Viatris
54 5West-ward Pharmaceutical Corp
55 5Wockhardt
01 1Ampoule
02 1CAPSULE, DELAYED RELEASE;ORAL
03 1Capsule
04 2INF
05 6INJ
06 62INJECTABLE;INJECTION
07 3Injectable And Infusion Solution
08 3Injectable And Perfusion Solution
09 60Injectable Solution
10 3Injectable Suspension
11 5Injection
12 1KIT
13 2Liquid Injection
14 4Lyophilised Injection
15 1Octreotide 0.05Mg 10 Units Parenteral Use
16 1Octreotide 0.1Mg 10 Units Parenteral Use
17 1Octreotide 0.5Mg 10 Units Parenteral Use
18 1Octreotide 0.5Mg 3 Units' Parenteral Use
19 5Octreotide 100Mcg 5 Units Parenteral Use
20 1Octreotide 10Mg 1 Unit Parenteral Use
21 4Octreotide 1Mg 1 Unit Parenteral Use
22 1Octreotide 20Mg 1 Unit Parenteral Use
23 1Octreotide 30Mg 1 Unit Parenteral Use
24 4Octreotide 500Mcg 5 Units Parenteral Use
25 5Octreotide 50Mcg 5 Units Parenteral Use
26 5POWDER FOR SUSPENSION, SUSTAINED-RELEASE
27 3Powder And Solvent For Extended-Release Injectable Suspension
28 7Powder And Solvent For Injectable Suspension
29 6Powder And Solvent For Prolonged-Release Injectable Suspension
30 3Powder And Solvent For Prolonged-Release Suspension For Injection
31 34Powder For Injection
32 2Pre-Filled Syringe
33 1Prolonged Release Solution For Injection
34 5SOLUTION
35 1SOLUTION;SUBCUTANEOUS
36 1Solution
37 30Solution For Injection
38 4Solution For Injection And Infusion
39 5Solution For Injection In Pre-Filled
40 1Solution For Injection In Pre-Filled Syringe
41 1Solution For Injection Or Concentrate For Solution For Infusion
42 11Solution For Injection/Infusion
43 1Solution for Injection
44 3Vial
45 18injection
46 30Blank
01 13Allowed
02 41Approved
03 10Authorised
04 12Authorized
05 10Cancelled
06 18DISCN
07 62Deregistered
08 4Generic
09 6Originator
10 19Prescription
11 43RX
12 4Withdrawn
13 109Blank
01 1BYNFEZIA PEN
02 4Longastatina
03 3Longastatina Lar
04 1MYCAPSSA
05 1Mycapssa
06 39OCTREOTIDE ACETATE
07 12OCTREOTIDE ACETATE (PRESERVATIVE FREE)
08 4OCTREOTIDE ACETATE OMEGA
09 3OCTREOTIDE ACETATE PRESERVATIVE FREE
10 1OCTREOTIDE BIOINDUSTRY LIM
11 3OCTREOTIDE FOR INJECTABLE SUSPENSION
12 4OCTREOTIDE SUN
13 1OCTREOTIDE TEVA 20
14 1OCTREOTIDE TEVA 30
15 2Octra
16 2Octreo-Ratiopharm
17 4Octreotida Gp-Pharm
18 2Octreotida Hospira
19 3Octreotida Ratiopharm
20 4Octreotida Sun
21 3Octreotida Teva
22 17Octreotide
23 6Octreotide (SUN)
24 3Octreotide 2Care4
25 3Octreotide Abacus Medicine
26 3Octreotide Acetate
27 6Octreotide Acetate Omega (Canada)
28 2Octreotide Bendalis
29 2Octreotide Bijon
30 4Octreotide Campus
31 3Octreotide Csc
32 12Octreotide Depot
33 3Octreotide Fresenius Kabi
34 6Octreotide GH
35 4Octreotide Hospira
36 4Octreotide Labatec
37 2Octreotide Orifarm
38 4Octreotide Sun
39 9Octreotide Teva
40 3Octreotide-Mepha LA
41 1Octroflex
42 1Oczyesa
43 2Olatuton
44 6SANDOSTATIN
45 6SANDOSTATIN LAR
46 3SIROCTID
47 47Sandostatin
48 1Sandostatin 1Mg/5Ml Injection
49 2Sandostatin 0.05
50 2Sandostatin 0.1
51 2Sandostatin 0.5
52 12Sandostatin LAR
53 3Sandostatin LAR Fertigspritzen
54 37Sandostatin Lar
55 1Sandostatin Lar 10Mg
56 1Sandostatin Lar 20Mg
57 1Sandostatin Lar 30Mg
58 3Sandostatina
59 2Sandostatin®
60 3Siroctid
61 3TREOJECT
62 3Treoject
63 15Blank
01 48Australia
02 11Canada
03 8Estonia
04 16India
05 1Iran
06 36Italy
07 14Malta
08 3Moldova
09 8South Africa
10 22Spain
11 103Sweden
12 13Switzerland
13 3Turkey
14 64USA
15 1Ukraine
Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
Regulatory Info :
Registration Country : India
Brand Name : Octreotide Acetate
Dosage Form : Injectable Suspension
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
Regulatory Info :
Registration Country : India
Brand Name : Octreotide Acetate
Dosage Form : Injectable Suspension
Dosage Strength : 20MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
Regulatory Info :
Registration Country : India
Brand Name : Octreotide Acetate
Dosage Form : Injectable Suspension
Dosage Strength : 30MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : SANDOSTATIN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 0.05MG BASE/ML
Packaging :
Approval Date : 1988-10-21
Application Number : 19667
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SANDOSTATIN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 0.1MG BASE/ML
Packaging :
Approval Date : 1988-10-21
Application Number : 19667
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SANDOSTATIN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 0.5MG BASE/ML
Packaging :
Approval Date : 1988-10-21
Application Number : 19667
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : SANDOSTATIN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 0.2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1991-06-12
Application Number : 19667
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : SANDOSTATIN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 1MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1991-06-12
Application Number : 19667
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SANDOSTATIN LAR
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 10MG BASE/VIAL
Packaging :
Approval Date : 1998-11-25
Application Number : 21008
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SANDOSTATIN LAR
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 20MG BASE/VIAL
Packaging :
Approval Date : 1998-11-25
Application Number : 21008
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SANDOSTATIN LAR
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 30MG BASE/VIAL
Packaging :
Approval Date : 1998-11-25
Application Number : 21008
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Prescription
Registration Country : Canada
OCTREOTIDE (OCTREOTIDE ACETATE)
Brand Name : OCTREOTIDE ACETATE OMEGA
Dosage Form : SOLUTION
Dosage Strength : 50MCG/ML
Packaging : 1ML
Approval Date :
Application Number : 2248639
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
OCTREOTIDE (OCTREOTIDE ACETATE)
Brand Name : OCTREOTIDE ACETATE OMEGA
Dosage Form : SOLUTION
Dosage Strength : 100MCG/ML
Packaging : 1ML
Approval Date :
Application Number : 2248640
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
OCTREOTIDE (OCTREOTIDE ACETATE)
Brand Name : OCTREOTIDE ACETATE OMEGA
Dosage Form : SOLUTION
Dosage Strength : 500MCG/ML
Packaging : 1ML
Approval Date :
Application Number : 2248641
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
OCTREOTIDE (OCTREOTIDE ACETATE)
Brand Name : OCTREOTIDE ACETATE OMEGA
Dosage Form : SOLUTION
Dosage Strength : 200MCG/ML
Packaging : 5ML
Approval Date :
Application Number : 2248642
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
OCTREOTIDE (OCTREOTIDE ACETATE)
Brand Name : OCTREOTIDE FOR INJECTABLE SUSPENSION
Dosage Form : KIT
Dosage Strength : 10MG/VIAL
Packaging :
Approval Date :
Application Number : 2503751
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
OCTREOTIDE (OCTREOTIDE ACETATE)
Brand Name : OCTREOTIDE FOR INJECTABLE SUSPENSION
Dosage Form : POWDER FOR SUSPENSION, SUSTAINED-RELEASE
Dosage Strength : 20MG/VIAL
Packaging :
Approval Date :
Application Number : 2503778
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
OCTREOTIDE (OCTREOTIDE ACETATE)
Brand Name : OCTREOTIDE FOR INJECTABLE SUSPENSION
Dosage Form : POWDER FOR SUSPENSION, SUSTAINED-RELEASE
Dosage Strength : 30MG/VIAL
Packaging :
Approval Date :
Application Number : 2503786
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Sandostatin Lar 10Mg
Dosage Form : INJ
Dosage Strength : 10mg
Packaging : 2.5X1mg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Sandostatin Lar 20Mg
Dosage Form : INJ
Dosage Strength : 20mg
Packaging : 2.5X1mg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
